BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32371137)

  • 1. PARP inhibitor treatment in ovarian and breast cancer.
    Weil MK; Chen AP
    Curr Probl Cancer; 2011; 35(1):7-50. PubMed ID: 21300207
    [No Abstract]   [Full Text] [Related]  

  • 2. Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review.
    Alemzadeh E; Allahqoli L; Mazidimoradi A; Alemzadeh E; Ghasemi F; Salehiniya H; Alkatout I
    Oncol Res; 2024; 32(5):831-847. PubMed ID: 38686048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Development of Selective Antitumor Inhibitors That Target PARP-1.
    Liu F; Chen J; Li X; Liu R; Zhang Y; Gao C; Shi D
    J Med Chem; 2023 Dec; 66(24):16464-16483. PubMed ID: 38088333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing and computational design of PARP inhibitors as SARS-CoV-2 inhibitors.
    Rampogu S; Jung TS; Ha MW; Lee KW
    Sci Rep; 2023 Jun; 13(1):10583. PubMed ID: 37386052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of efflux transporters by poly ADP-ribose polymerase inhibitors.
    Deng F; Sistonen J; Neuvonen M; Niemi M
    Basic Clin Pharmacol Toxicol; 2023 Oct; 133(4):428-436. PubMed ID: 37539467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on the management of adverse reactions induced by poly(ADP-ribose) polymerase inhibitors.
    Society of Obstetrics and Gynecology of Zhejiang Medical Association ; Society of Urology of Zhejiang Medical Association ; Committee of Breast Cancer of Zhejiang Anticancer Association ; Committee of Clinical Pharmacy on Oncology of Zhejiang Anticancer Association (preparation) ; Committee of Urology of Zhejiang Society for Mathematical Medicine
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 51(6):765-774. PubMed ID: 36915979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic landscaping of high-grade serous ovarian carcinoma identifies stearoyl-CoA desaturase 5 as a potential predictive biomarker for poly(ADP-ribose) polymerase inhibitor response.
    Kim SI; Kim H; Dan K; Park HB; Lee C; Kim HS; Chung HH; Kim JW; Park NH; Han D; Lee M
    Clin Transl Med; 2024 May; 14(5):e1693. PubMed ID: 38720404
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management.
    Yang C; Han Z; Zhan W; Wang Y; Feng J
    Front Genet; 2023; 14():1157258. PubMed ID: 37035748
    [No Abstract]   [Full Text] [Related]  

  • 9. Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension-Mechanisms and Mitigation.
    Hypertension; ; . PubMed ID: 36756872
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.